购物车
您的购物车当前为空
InhA-IN-8 (compound 6c) 为一种抗结核分枝杆菌InhA(烯酰ACP还原酶)的口服有效抑制剂。此化合物对Mtb UalRv显示出较高的抑制效果(MIC = 0.5-1 μg/mL)。InhA-IN-8 同时也适用于进行急性结核模型小鼠的实验研究。
InhA-IN-8 (compound 6c) 为一种抗结核分枝杆菌InhA(烯酰ACP还原酶)的口服有效抑制剂。此化合物对Mtb UalRv显示出较高的抑制效果(MIC = 0.5-1 μg/mL)。InhA-IN-8 同时也适用于进行急性结核模型小鼠的实验研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
| 产品描述 | InhA-IN-8 (compound 6c) serves as an orally effective inhibitor of the Mycobacterium tuberculosis enzyme InhA (enoyl-ACP reductase). This compound demonstrates robust inhibitory activity against Mtb H37Rv, with a minimum inhibitory concentration (MIC) ranging from 0.5 to 1 μg/mL. Additionally, InhA-IN-8 is utilized in studies involving acute tuberculosis models in mice. |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准 |
对于不同动物的给药剂量换算,您也可以参考 更多